TerminatedNot Applicable

Comparison of the Performance of ICM and CIED in Detecting AF

Stopped: Recruitment to study was insufficient. This was despite extending the recruitment period. Decision taken to terminate study due to lack of recruitment.

United Kingdom6 participantsStarted 2021-10-04

Plain-language summary

The aim of this project is to study the performance of the two most commonly used Implantable Cardiac Monitors in detecting AF episodes and explore how the new connectivity can empower patients and improve patient care.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the trial. * Male or Female. * Aged 18 years or above. * History of paroxysmal and persistent AF. * Dual-chamber pacemaker, Implantable cardioverter defibrillator (ICD) or cardiac resynchronisation therapy (CRT) device with a functioning atrial lead, able to record electrograms and remote monitoring. Exclusion Criteria: * Diagnosis of permanent AF. * Contra-indications for implantable cardiac monitor. * Unable to comply with the follow-up schedule.

What they're measuring

Assessment of Performance of Confirm Rx ICM and Reveal LINQ ICM in Detecting AF Episodes in Comparison to CIED

Timeframe: During follow-up (6 months)

Trial details

NCT IDNCT04940156

SponsorOxford University Hospitals NHS Trust

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-23

Results submitted2024-06-19

View on ClinicalTrials.gov More Atrial Fibrillation trials